IP Library Granted Patent US 6,906,036
Granted Patent B2
US 6,906,036 · App. 10/153,185 · Granted Jun 14, 2005

Anti-aging and wound healing compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,906,036
App. No.
10/153,185
Granted
Jun 14, 2005
Kind
B2
Abstract

The invention provides inhibitors of matrix metalloproteinases that are useful for encouraging the development of healthy skin and for treating wounds. The inhibitors are peptides having sequences related to cleavage regions of the proenzyme forms of matrix metalloproteinases. The peptide inhibitors of the invention can be formulated into therapeutic compositions, lotions, creams, skin covering and wound dressings that facilitate healing and healthy skin development, discourage scarring and wrinkling and ameliorate the effects of healing.

Claims (7)

1. An isolated peptide consisting of SEQ ID NO:11, SEQ ID NO:12, or SEQ ID NO:13, wherein the peptide can inhibit matrix metalloproteinase-2.

2. A composition that comprises a therapeutically effective amount of a peptide that consists of SEQ ID NO:11, SEQ ID NO:12, or SEQ ID NO:13, and a pharmaceutically acceptable carrier.

3. The composition of claim 2 wherein the peptide can inhibit proteinase activity of any one of matrix metalloproteinase-1, matrix metalloproteinase-2, matrix metalloproteinase-3, matrix metalloproteinase-4, matrix metalloproteinase-5, matrix metalloproteinase-6, matrix metalloproteinase-7, matrix metalloproteinase-8, and matrix metalloproteinase-9, matrix metalloproteinase-10, matrix metalloproteinase-11, matrix metalloproteinase-12, or matrix metalloproteinase 13.

4. A wound dressing that comprises a peptide consisting of SEQ ID NO:11, SEQ ID NO:12, or SEQ ID NO:13, wherein the peptide can inhibit a matrix metalloproteinase activity.

5. The wound dressing of claim 4 , wherein the dressing promotes wound healing, prevents scarring, improve skin tone, reduces wrinkling, or stimulates the development of a smooth, healthy skin.

6. A lotion that comprises a peptide consisting of SEQ ID NO:11, SEQ ID NO:12, or SEQ ID NO:13, wherein the peptide can inhibit a matrix metalloproteinase or promote the growth of fibroblasts.

7. The lotion of claim 6 , wherein the lotion improves skin tone, reduces wrinkling, or stimulates the development of a smooth, healthy skin.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jun 30, 2022
From: CITIBANK, N.A.
To: AVENT, INC.; AVANOS MEDICAL SALES, LLC
Reel/Frame 060557/0062 →
INTELLECTUAL PROPERTY SECURITY INTEREST ASSIGNMENT AGREEMENT Recorded Jan 23, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: CITIBANK, N.A.
Reel/Frame 048173/0137 →
SECURITY INTEREST Recorded Apr 6, 2015
From: AVENT, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 035375/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: AVENT, INC.
Reel/Frame 034754/0424 →